, Tracking Stock Market Picks
Enter Symbol:
Compagnie Generale De Gephysqu (CGG) [hlAlert]

down 81.17 %

Compagnie Generale De Gephysqu (CGG) upgraded to Buy by Standpoint Research

Posted on: Friday,  May 3, 2013  11:25 AM ET by Standpoint Research

Standpoint Research rated Buy Compagnie Generale De Gephysqu (NYSE: CGG) on 05/03/2013, when the stock price was $24.33.
Since then, Compagnie Generale De Gephysqu has lost 81.18% as of 08/28/2015's recent price of $4.58.
If you would have followed this Standpoint Research's recommendation on CGG, you would have lost 81.17% of your investment in 847 days.

CGG Veritas is a manufacturer of geophysical equipment, and a provider of a range of services (including seismic data acquisition and related processing and interpretation software) principally to clients in the oil and gas exploration and production industry. The Company?s operations are organized into two segments: Services and Equipment. The Company is a provider of data processing and imaging services, which it provides through a worldwide network of 28 open seismic data processing centers and 12 client-dedicated centers. It also offers the Hampson-Russell software. It has an installed base of more than 1400 licenses at over 500 petroleum and service companies worldwide. During the year ended December 31, 2008, Services accounted for 71% and Equipment accounted for 29% of its consolidated revenues. In January 2009, TGS-NOPEC Geophysical Company ASA sold all its 10.1% interest in Wavefield Inseis ASA to CGG Veritas.

Standpoint Research provides independent equity research that is free from the conflicts of asset management, investment banking, proprietary trading, and fee-for-research arrangements. We provide thorough analysis, diagnostics and forecasts on domestic and international equities and markets backed by alpha-generating variables back-tested on many years of data. Standpoint Research currently advises and sells its research to pension funds, hedge funds and asset management firms. Wall Street analysts have an optimistic bias, while we are more objective. In fact some of the variables in our model that are looked at as positives by Wall Street actually carry negative weight in our model. We have a strict discipline that includes running our proprietary 155-variable valuation and diagnostics model with a personal and subjective overlay that has been proven to add value. The effectiveness is demonstrated through our impressive track record of recommendations.
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy